EchoStor Technologies announced it has acquired Pennant Networks, a technology consulting firm focused on providing solutions and managed services to the life sciences sector. The deal strengthens EchoStor’s managed services capabilities and expands its presence in highly regulated industries where compliance, security, and specialized technical expertise are critical.
Pennant Networks works with organizations across the life sciences ecosystem, including research and clinical-stage companies, biotech venture capital firms, global pharmaceutical companies, contract biomanufacturers, and scientific research organizations. The company is known for its specialized expertise in industry-specific security, compliance requirements, and technology environments that support scientific research and drug development.
EchoStor said the acquisition aligns with its 2026 growth strategy, which aims to expand the company’s services portfolio, deepen its vertical industry expertise, and extend its reach into new markets. By integrating Pennant Networks, EchoStor gains a managed services platform tailored for life sciences organizations along with a roster of enterprise clients in the sector.
The acquisition also expands EchoStor’s geographic footprint across the Boston life sciences corridor and into other key markets in the United States and internationally. EchoStor stated that Pennant Networks will continue operating with its existing teams and service model while gaining access to EchoStor’s broader technical capabilities, manufacturer partnerships, and delivery resources.
Financial terms of the transaction were not disclosed.
EchoStor Technologies, founded in 2005, provides IT solutions and services designed to help organizations modernize technology environments and streamline operations through data-driven strategies.
Pennant Networks was founded in 2021 and specializes in consulting and technology services for life sciences organizations. Its offerings span datacenter infrastructure, end user productivity tools, cybersecurity, cloud and SaaS platforms, and AI implementation support designed to help customers adapt to evolving technological and regulatory demands.
KEY QUOTES:
“This acquisition represents a strategic step forward as we expand into highly specialized, high-value markets. Life Sciences demands more than technical expertise; it requires a partner who understands complex regulatory frameworks, data integrity, security, and the operational discipline that defines the industry. Pennant’s team brings immediate credibility and proven services capabilities to leading Life Sciences organizations. This positions EchoStor for sustained growth in Life Sciences and advances our long-term vision of building a market-leading platform purpose-built for complex, regulated industries.”
Mike Johnson, CEO of EchoStor Technologies
“Our customers trust us because we understand their world — the compliance requirements, the funding cycles, the research timelines, the stakes. EchoStor shares that commitment to deep expertise and long-term relationships. With their resources behind us, we can do more for the clients we’ve served for years and reach Life Sciences organizations we couldn’t support on our own. This is the right move for everyone we serve.”
Thom Serra, CEO and Founder of Pennant Networks
